P839: GAIN OF CHROMOSOME 1Q LEADS TO HIGH EXPRESSION OF SNORD78 AND ABERRANT RIBOSOME METHYLATION
Duoduo Zhao(First Affiliated Hospital Zhejiang University), Niels Weinhold(German Cancer Research Center), Stefanie Huhn(Heidelberg University), Anna Luise Grab(German Cancer Research Center), Carsten Müller‐Tidow(Heidelberg University), Alexandra M. Poos(German Cancer Research Center), Maximilian Felix Blank(Heidelberg University), Rafael Zinz(Heidelberg University), Christian Rohde(Heidelberg University), Marc S. Raab(Unknown), Stefanie Göllner(Heidelberg University), Lukas John(University of Hohenheim), Fengbiao Zhou(Heidelberg University), Cornelius Pauli(German Cancer Research Center)
Cited by 0
Related Papers
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
|Blood|2018|492
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
|Leukemia|2018|452
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
|Nature Communications|2017|418
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
|Molecular Cell|2009|315